It is coming. Moderna in the news:

• Reducing R&D budget from $4.8B in 2024 to $3.6B-3.8B in 2027, ditching several programs.
• Many future vaccines aren’t moving fast enough to bolster the top or bottom line.
• Q2 revenue was $241M, a 43% drop from year earlier. Company’s Covid vaccine is not selling as expected.
• One analyst said Moderna would not show a profit until 2028.

Perhaps mRNA vaccines are not a one-way ticket to a financial windfall?

Click to read the article.